Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.

Inclusion Criteria: * men and women ≥ 18 years of age, * patients with type 1 diabetes for more than 2 years, * patients treated by insulin pump for more than 6 months, * patients using of real-time continuous glucose monitoring for more than 3 months, * patients able to evaluate the IPRA advices by connecting to IPRA© application 30 times a week, * patient able to provide written informed consent, * patient able to provide written non-disclosure agreement Exclusion Criteria: * pregnancy or breastfeeding, * current infectious disease, * patients with no smartphone® or Internet access, * adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty